statistiche ricercatore

Continente	#
NA - Nord America	461
AS - Asia	405
EU - Europa	246
SA - Sud America	59
AF - Africa	20
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.192

Nazione	#
US - Stati Uniti d'America	448
SG - Singapore	130
VN - Vietnam	96
CN - Cina	92
BR - Brasile	45
IE - Irlanda	44
IT - Italia	42
DE - Germania	38
SE - Svezia	38
HK - Hong Kong	34
FR - Francia	21
ZA - Sudafrica	18
TR - Turchia	14
NL - Olanda	13
BD - Bangladesh	11
FI - Finlandia	11
GB - Regno Unito	8
BE - Belgio	6
CA - Canada	5
CZ - Repubblica Ceca	5
IN - India	5
AR - Argentina	4
AT - Austria	4
IQ - Iraq	4
JP - Giappone	4
MX - Messico	4
RU - Federazione Russa	4
VE - Venezuela	3
AZ - Azerbaigian	2
BO - Bolivia	2
EC - Ecuador	2
ES - Italia	2
HN - Honduras	2
LT - Lituania	2
PH - Filippine	2
PL - Polonia	2
PY - Paraguay	2
BG - Bulgaria	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CO - Colombia	1
EG - Egitto	1
GR - Grecia	1
ID - Indonesia	1
JO - Giordania	1
KG - Kirghizistan	1
KH - Cambogia	1
KR - Corea	1
LA - Repubblica Popolare Democratica del Laos	1
MT - Malta	1
MY - Malesia	1
NI - Nicaragua	1
OM - Oman	1
PA - Panama	1
RS - Serbia	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
UA - Ucraina	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.192

Nome	#
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC)	176
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value	176
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer	173
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME	161
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer	150
Vaccines against coronaviruses: The state of the art	141
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC	103
An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children	79
Analgosedation in Pediatric Emergency Care: A Comprehensive Scoping Review	58
Totale	1.217

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	15	0	0	0	0	0	0	0	0	0	9	3	3
2021/2022	36	0	2	1	2	2	3	4	2	2	3	3	12
2022/2023	181	15	22	9	17	15	22	3	11	51	1	12	3
2023/2024	71	1	4	2	2	4	16	5	4	6	9	8	10
2024/2025	235	5	9	19	23	21	21	19	17	21	15	22	43
2025/2026	553	62	40	69	52	90	32	36	25	108	39	0	0
Totale													1.217